
About Consytel Life Sciences Private Limited
Data last updated:
Consytel Life Sciences Private Limited is a private limited company based in Secunderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2017PTC121396. Its GSTIN is 36AAHCC3345C1Z0 (Telangana).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹10.17 Lakh. It is led by directors including Swagatika Satpathy and Saurabh Dash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 205 6 – 1 – 285/17 And18 Gharonda Mahima Apts Padmarao Nagar, Secunderabad, Telangana, India – 500025.
As per the financials filed for FY 2024, the company reported a revenue of ₹39.03 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.11 Lakh (net margin 2.9%) and EBITDA of ₹2.35 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 89% over five years.
The company is associated with 1 brand: Consytel Life Sciences. As per MCA filings, the company has open charges of ₹11.3 Lakh on record.
Consytel Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0002227). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website consytel.com.
Recognitions & Rankings of Consytel Life Sciences
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0002227
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address205 6 – 1 – 285/17 And18 Gharonda Mahima Apts Padmarao Nagar, Secunderabad, Telangana, India – 500025
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Consytel Life Sciences Private Limited
Consytel Life Sciences operates one associated brand: Consytel Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Nature-derived malaria products are manufactured for immune health support. | consytel.com |
Business Activity of Consytel Life Sciences Private Limited
The main business activity of Consytel Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Consytel Life Sciences Private Limited FY 2025 filings available
Consytel Life Sciences Private Limited reported revenue of ₹39.03 Lakh (up 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Consytel Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 89% over five years, including 11% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Consytel Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.35 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Consytel Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Consytel Life Sciences are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Consytel Life Sciences Private Limited
Consytel Life Sciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swagatika Satpathy | Director | 01 Nov 2019 | 6 Years 11 Months | Current |
| Saurabh Dash | Director | 04 Nov 2022 | 3 Years 11 Months | Current |
| Sandhyarani Dash | Director | 22 Dec 2017 | 8 Years 9 Months | Current |
| Shubhendu Kumar Dash | Director | 22 Dec 2017 | 8 Years 9 Months | Current |
Peer Comparison of Consytel Life Sciences Private Limited
Consytel Life Sciences Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Andhra Pradesh Medtech Zone Limited | ₹39.97 Lakh (FY 2018) | •••• | •••• | 345.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Lifespark Technologies Private Limited | ₹39.55 Lakh (FY 2024) | •••• | •••• | -15.0% | •••• | Mumbai, Maharashtra, India |
| VMP Health Care India Private Limited | ₹39.47 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Thane, Maharashtra, India |
| Hi-Q Test Equipment Private Limited | ₹39.35 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Hyderabad, Telangana, India |
| Desbro Biosciences Private Limited | ₹39.35 Lakh (FY 2025) | •••• | •••• | 40.0% | •••• | Hyderabad, Telangana, India |
| Consytel Life Sciences Private Limited this company | ₹39.03 Lakh (FY 2024) | •••• | •••• | 11.0% | •••• | Secunderabad, Telangana, India |
| Transasia Diagnostics Solutions Limited | ₹39.03 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Mansarovar Holistic Private Limited | ₹39.02 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Bhopal, Madhya Pradesh, India |
| Innovenita Laboratories Private Limited | ₹38.97 Lakh (FY 2024) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Eurowin Sterisolutions Private Limited | ₹38.86 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Thrissur, Kerala, India |
| Bionix Medical Service India Private Limited | ₹38.63 Lakh (FY 2025) | •••• | •••• | -79.0% | •••• | Tenkasi, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Consytel Life Sciences by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Consytel Life Sciences Private Limited
Consytel Life Sciences Private Limited is audited by RAJU & SRINIVAS for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJU & SRINIVAS | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Consytel Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Consytel Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | Uco Bank | ₹11.3 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Consytel Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Consytel Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Consytel Life Sciences Private Limited
Consytel Life Sciences Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Saurabh Dash was appointed as Director on 04 Nov 2022.
Credit Ratings, Litigation & Regulatory Alerts for Consytel Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Consytel Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Consytel Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Consytel Life Sciences Private Limited
Consytel Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCC3345C1Z0 | Telangana | Active | 16 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Consytel Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Consytel Life Sciences Private Limited
Consytel Life Sciences is an active private limited company based in Secunderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 December 2017 (9+ years old) and is registered under CIN U24290TG2017PTC121396.
Consytel Life Sciences reported revenue of ₹39.03 Lakh for FY 2024 (up 11% YoY).
Consytel Life Sciences has 4 current directors:
- Swagatika Satpathy - Director
- Saurabh Dash - Director
- Sandhyarani Dash - Director
- Shubhendu Kumar Dash - Director
Consytel Life Sciences reported a net profit of ₹1.11 Lakh (net margin 2.9%) and EBITDA of ₹2.35 Lakh (EBITDA margin 6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Consytel Life Sciences is 13% over three years and 89% over five years. In the latest year (FY 2024) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Consytel Life Sciences is 36AAHCC3345C1Z0, registered in Telangana.
The CIN (Corporate Identification Number) of Consytel Life Sciences is U24290TG2017PTC121396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Consytel Life Sciences was incorporated on 22 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Consytel Life Sciences by revenue are Andhra Pradesh Medtech Zone Limited, Lifespark Technologies Private Limited, VMP Health Care India Private Limited, Hi-Q Test Equipment Private Limited, Desbro Biosciences Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).
Saurabh Dash was appointed as Director on 04 Nov 2022. Swagatika Satpathy was appointed as Director on 01 Nov 2019. Sandhyarani Dash was appointed as Director on 22 Dec 2017. Consytel Life Sciences has 4 board changes on record in total.
Yes, Consytel Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).